Atlas Trials

Validation of a Urine-based Assay With Genomic Markers for Predicting Recurrence for Non-muscle Invasive Bladder Cancer

Clinical trial NCT02969109 · COMPLETED

Trial details

NCT number
NCT02969109
Sponsor
Genomic Health®, Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
Non-muscle Invasive Bladder Cancer
Start date
2015-10-01
Primary completion
2018-09-18
Enrollment
417

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.